Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Phase II Study of Docetaxel Before Degarelix in Patients With Newly Diagnosed Metastatic Prostate Cancer. [Phase 2]
Phase II study evaluating docetaxel before degarelix in newly diagnosed metastatic prostate cancer; results have been posted in 2025.
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8) [Phase 1, Phase 2]
Phase 1/2 study of nivolumab with BMS-986253 in hormone-sensitive prostate cancer has posted results. The trial status is active but not rec…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad) [Phase 1]
A Phase 1 (Phase IB) trial evaluating Radium-223 dichloride in combination with niraparib for castration-resistant, metastatic prostate canc…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer [NA]
This clinical trial update reports on caloric restriction before surgery for patients with breast cancer, endometrial cancer, or prostate ca…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
A terminated Mayo Clinic trial investigated associations between chemotherapy-induced nausea in genitourinary, sarcoma, and melanoma cancers…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-25Clinical Trial Update: Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer [Phase 1]
This document reports a Phase 1 clinical trial update for ADXS-504 immunotherapy in patients with recurrent prostate cancer, noting the stud…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy [Phase 2]
A Phase 2 clinical trial evaluating sacituzumab govitecan in metastatic castration-resistant prostate cancer that progressed on second-gener…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer [Phase 4]
A Phase 4 clinical trial update evaluating the long-term safety of Lutetium-177 vipivotide tetraxetan in participants with prostate cancer, …
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging [NA]
This clinical trial update reports results on using micro-ultrasound imaging to improve prediction of the location and extent of prostate ca…
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Novel Robotic Prostatectomy Technique for Early Urinary Continence
Completed clinical trial assessing a novel robotic prostatectomy technique designed to improve early urinary continence in prostate cancer p…
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer [Phase 2, Phase 3]
A Phase 2/3 clinical trial reports results on the clinical accuracy of Gallium-68 PSMA PET/CT imaging for detecting biochemical recurrence o…
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer [Phase 3]
Phase 3 trial evaluating goserelin 10.8 mg injection for advanced prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating intermittent androgen deprivation therapy with or without stereotactic body radiotherapy for hormone-sen…
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: Randomized Trial of HIFU vs. Cryo for Prostate Cancer [NA]
A randomized trial comparing High-Intensity Focused Ultrasound (HIFU) versus cryoablation for prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: Docetaxel Versus Cabazitaxel Post Abiraterone or Enzalutamide [Phase 2]
A Phase 2 study comparing docetaxel versus cabazitaxel in patients with metastatic prostate cancer after progression on abiraterone or enzal…
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer [Phase 2]
Phase 2 trial evaluating hydroxychloroquine to increase PAR-4 tumor suppressor levels in oligometastatic/prostate cancer; study completed wi…
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC [Phase 1]
Phase 1 clinical trial evaluating the safety and preliminary efficacy of Universal PSMA CAR-T cells in patients with refractory metastatic c…
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate Cancer
A completed clinical trial evaluating whether intratumoral heterogeneity on PSMA and FDG PET/CT imaging can predict invasion and prognosis i…
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy [EARLY_Phase 1]
A Phase 1 study evaluating systemic light exposure to prevent frailty in older patients with prostate cancer receiving hormonal therapy has …
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model
A completed clinical trial from Abramson Cancer Center at Penn Medicine evaluated an alternative genetics-based cancer care delivery model, …
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate-Specific Membrane Antigen [Phase 1]
The document reports the completion of a Phase 1 clinical trial evaluating [177Lu]Lu-BQ7876 for targeting PSMA in prostate cancer.
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413 [Phase 1]
A Phase 1 trial evaluating a Technetium-99m labeled PSMA-targeted radiopharmaceutical, BQ0413, for molecular imaging in prostate cancer. The…
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8 [Phase 1]
Phase 1 study evaluating molecular imaging of gastrin-releasing peptide receptors using Technetium-99m-labeled DB8 in prostate cancer and br…
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Evaluation of Prostate Cancer Margins
Completed clinical trial evaluating margins in prostate cancer sponsored by Intuitive Surgical.
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial [NA]
This clinical trial update covers the MAPS trial, which investigates MRI-guided, dose-escalated salvage radiotherapy after prostatectomy, wi…